T cell immunity and cytokine receptor signaling
T cell immunity and cytokine receptor signaling
批准号:
7907205
负责人:
Thomas R Malek
金额:
$38.25万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2010-08-31
关键词:
AntigensAutoimmune DiseasesAutoimmunityBiologicalBiological ModelsCD8B1 geneCell ProliferationCellsCytokine ReceptorsDataDefectDevelopmentEffector CellEventGenetic PolymorphismGrantHumanImmune responseImmunityIn VitroIndividualInfectious AgentInterleukin-15Interleukin-2LifeMediatingMemoryMolecularMolecular TargetPathway interactionsPeripheralProcessProductionProliferatingReceptor SignalingRegulationRoleSignal TransductionStreamSusceptibility GeneT memory cellT-Cell DevelopmentT-LymphocyteTestingTranscription Repressor/CorepressorTransgenic OrganismsUpper armbasein vitro Modelin vivomouse modelnovelnovel therapeuticsprogramsresearch studyresponsetoolvaccine development
中文摘要
活化的T细胞发育成武装效应细胞或最终持续存在的过程
因为长寿记忆细胞正变得更好地被理解。通过IL-1介导的信号转导
2R对这些过程有显著的贡献。IL-2促进最佳T效应反应和
对于广泛的效应细胞在体外的增殖和发育是必不可少的。此外,最近
数据表明,初级反应过程中的IL-2信号可能对记忆CD8 T至关重要
细胞在召回抗原挑战时进行增殖和调节效应器活性。不过,
调节效应器对记忆编程的分子机制和精确的
IL-2对这些过程的贡献在很大程度上仍未确定。在我们上一次的资助期间,
我们开发了一种培养系统,模拟效应和记忆T细胞的发育和
外周T细胞在IL-2R信号通路中选择性缺陷的独特小鼠模型
细胞。这些实验工具对于直接分析IL-2依赖是特别有用的
分子事件控制效应器和内存编程。利用这些,我们发现了一种
在IL-2抑制自身产生的新的自动调节环路中,这可能是一个重要的
效应器和/或内存生产的检查点。这一抑制途径依赖于
转录抑制因子Blimp-1因此,这项提案的主要目标是建立
IL-2信号调节效应器和存储单元编程的分子基础
确定Blimp-1依赖的活化T细胞调节的生物学相关性。这个
具体目标是:1)研究IL-2R?信号如何调节个体下游
活化的CD4和CD8T细胞的分子靶点;2)确定IL-2R的相关性
体内对名义抗原和感染性免疫反应发展过程中的信号转导
3)直接评价IL-2依赖的Blimp-1在T细胞免疫中的作用
回应。
英文摘要
The processes by which activated T cells develop into armed effector cells or ultimately persist
as long-lived memory cells are becoming better understood. Signal transduction through the IL-
2R prominently contributes to these processes. IL-2 promotes optimal T effector responses and
is essential for extensive effector cell proliferation and development in vitro. Furthermore, recent
data suggest that IL-2 signaling during the primary response may be critical for memory CD8 T
cells to proliferate and mediate effector activity upon a recall antigenic challenge. Nevertheless,
the molecular mechanism that regulates effector versus memory programming and the precise
contribution by IL-2 to these processes remains largely undefined. During our last grant period,
we developed a culture system that models effector and memory T cell development and
characterized unique mouse models with selective defects in IL-2R signaling by peripheral T
cells. These experimental tools are especially useful for direct analysis of IL-2-dependent
molecular events controlling effector and memory programming. Utilizing these, we uncovered a
novel auto-regulatory loop in which IL-2 inhibits its own production that may be an important
checkpoint for effector and/or memory production. This inhibitory pathway depends upon the
transcriptional repressor Blimp-1.Thus, the major objectives for this proposal are to establish the
molecular basis by which IL-2 signaling regulates effector and memory cell programming and to
ascertain the biological relevance of Blimp-1-dependent regulation of activated T cells. The
specific aims are: 1) To investigate how IL-2R¿ signaling regulates individual down-stream
molecular targets in activated CD4 and CD8 T cells; 2) to determine the relevance of IL-2R
signaling during the development of immune responses in vivo to nominal antigen and infectious
agents; and 3) to directly evaluate the function of IL-2-dependent Blimp-1 in T cell immune
responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predoctoral Training in Translational Immunology
-
批准号:10493792
-
项目类别:
-
资助金额:$10.56万
-
财政年份:2022
-
负责人:Thomas R Malek
-
依托单位:
Predoctoral Training in Translational Immunology
-
批准号:10684090
-
项目类别:
-
资助金额:$16.14万
-
财政年份:2022
-
负责人:Thomas R Malek
-
依托单位:
Bi-functional fusion proteins to regulate autoimmunity
-
批准号:10373388
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2021
-
负责人:Thomas R Malek
-
依托单位:
Bi-functional fusion proteins to regulate autoimmunity
-
批准号:10528479
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2021
-
负责人:Thomas R Malek
-
依托单位:
IL-2R-dependent mechanisms in regulation of Treg homeostasis and autoimmunity
-
批准号:10304194
-
项目类别:
-
资助金额:$61.94万
-
财政年份:2019
-
负责人:Thomas R Malek
-
依托单位:
Low-dose IL-2 in Established T1D
-
批准号:9761962
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Thomas R Malek
-
依托单位:
Low dose IL-2 and human regulatory T cells
-
批准号:10061539
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2017
-
负责人:Thomas R Malek
-
依托单位:
Low dose IL-2 and human regulatory T cells
-
批准号:10308487
-
项目类别:
-
资助金额:$60.33万
-
财政年份:2017
-
负责人:Thomas R Malek
-
依托单位:
Low-dose IL-2 in Established T1D
-
批准号:9544827
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Thomas R Malek
-
依托单位:
A novel IL-2 biologic and tumor immunity
-
批准号:9185950
-
项目类别:
-
资助金额:$20.03万
-
财政年份:2015
-
负责人:Thomas R Malek
-
依托单位:
IL-2-dependent mechanisms in T1D
-
批准号:8439428
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2012
-
负责人:Thomas R Malek
-
依托单位:
IL-2-dependent mechanisms in T1D
-
批准号:8554761
-
项目类别:
-
资助金额:$32.11万
-
财政年份:2012
-
负责人:Thomas R Malek
-
依托单位:
The immunobiology of CD4+ CD25+ T regulatory cells
-
批准号:8384876
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2010
-
负责人:Thomas R Malek
-
依托单位:
The immunobiology of CD4+ CD25+ T regulatory cells
-
批准号:8580546
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2010
-
负责人:Thomas R Malek
-
依托单位:
The immunobiology of CD4+ CD25+ T regulatory cells
-
批准号:8039479
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2010
-
负责人:Thomas R Malek
-
依托单位:
The immunobiology of CD4+ CD25+ T regulatory cells
-
批准号:8204397
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2010
-
负责人:Thomas R Malek
-
依托单位:
The immunobiology of CD4+ CD25+ T regulatory cells
-
批准号:8769997
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2010
-
负责人:Thomas R Malek
-
依托单位:
Memory T Cells in Tumpr Immunity
-
批准号:7226410
-
项目类别:
-
资助金额:$23.42万
-
财政年份:2006
-
负责人:Thomas R Malek
-
依托单位:
Immunobiology of CD4+CD25+ T regulatory cells
-
批准号:6823665
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2004
-
负责人:Thomas R Malek
-
依托单位:
Immunobiology of CD4+CD25+ T regulatory cells
-
批准号:7224940
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2004
-
负责人:Thomas R Malek
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: